ISR Immune System Regulation Holding AB (publ)

OM:ISR Stock Report

Market Cap: SEK 96.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

ISR Immune System Regulation Holding Management

Management criteria checks 2/4

Key information

Ola Winqvist

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.2yrs
CEO ownershipn/a
Management average tenure2.2yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

We're Not Very Worried About ISR Immune System Regulation Holding's (STO:ISR) Cash Burn Rate

Aug 11
We're Not Very Worried About ISR Immune System Regulation Holding's (STO:ISR) Cash Burn Rate

A Look At The Fair Value Of ISR Immune System Regulation Holding AB (publ) (STO:ISR)

Jul 02
A Look At The Fair Value Of ISR Immune System Regulation Holding AB (publ) (STO:ISR)

Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Mar 08
Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Nov 18
Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Jul 27
Is ISR Immune System Regulation Holding (STO:ISR) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching ISR Immune System Regulation Holding's (STO:ISR) Cash Burn Situation

Mar 26
Here's Why We're Watching ISR Immune System Regulation Holding's (STO:ISR) Cash Burn Situation

We Think ISR Immune System Regulation Holding (STO:ISR) Can Afford To Drive Business Growth

Dec 11
We Think ISR Immune System Regulation Holding (STO:ISR) Can Afford To Drive Business Growth

CEO

Ola Winqvist (60 yo)

5.2yrs

Tenure

Professor Ola S. Winqvist, MD, PhD is Co-Founder at ISR Immune System Regulation Holding AB (publ) and also serves as Chief Executive Officer since October 2021. He has been a Member of Scientific Board at...

Leadership Team

NamePositionTenureCompensationOwnership
Ola Winqvist
Co-founder & CEO5.2yrsno datano data
Gunnar Jardelöv
Co-Founder & Directorno datano datano data
Jonas Winqvist
COO & CFO2.2yrsno datano data
Johan Sjodahl
Chief Scientific Officer2.2yrsno datano data
Nigel Goodman
Chief of Clinical Operations1.2yrsno datano data
Jacob Harker
Chief of Manufacturing Officer1.2yrsno datano data

2.2yrs

Average Tenure

56.5yo

Average Age

Experienced Management: ISR's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gunnar Jardelöv
Co-Founder & Director7.2yrsno datano data
Anders Milton
Independent Chairman of the Board7.2yrsno datano data
Bengt Fellstrom
Director1.2yrsno datano data
Erik Kinnman
Director1.2yrsno datano data

4.2yrs

Average Tenure

75yo

Average Age

Experienced Board: ISR's board of directors are considered experienced (4.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/03/12 04:27
End of Day Share Price 2022/12/13 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ISR Immune System Regulation Holding AB (publ) is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ethel Szpilman LuvallRedeye